Endocrine Society champions resolution passed by House of Delegates On June 10, the American Medical Association (AMA) House of Delegates passed the Endocrine Society’s resolution to improve access to anti-obesity medications. In the resolution, the AMA committed to advocating for reducing the burden of prior authorization, when healthcare providers must seek insurance plan approval before...
The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate. The legislation will ensure that Medicare and Medicaid beneficiaries have access to effective anti-obesity medications. Medicare coverage of anti-obesity medications is currently prohibited under law. Access to these medications would benefit millions of Americans. More than...
“Cosmic Bubble” image features cells from a thyroid cancer subtype Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”. The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...
The Endocrine Society has selected Yoshitomo Hoshino, MD, PhD, as the recipient of its 2025 C. Wayne Bardin, MD, International Travel Award for his outstanding ENDO abstract and research contributions to the care of patients with bone health disorders. The C. Wayne Bardin, MD, International Travel Award was created in honor of Past President Wayne...
The Endocrine Society has appointed Manuel Tena-Sempere, MD, PhD, of the University of Cordoba in Spain, as the next editor-in-chief of its flagship basic science journal, Endocrinology, starting January 2026. Manuel Tena-Sempere is a professor of physiology at the University of Cordoba, a research group leader at the biomedical research institute of Cordoba (IMIBIC) and...
Just when you thought it was time to roll up the red carpet, four Endocrine Society members have recently been announced as taking home their fair share of prestigious awards that recognize outstanding leaders in research and science. First off, the 2025 Breakthrough Prize for Life Science has been presented to Daniel J. Drucker, MD,...
The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity. The administration decided not to implement a proposal that would have allowed Medicare and Medicaid to cover anti-obesity medications for weight loss. Many Medicare and Medicaid...
A major reorganization of the U.S. Department of Health and Human Services (HHS) — including massive cuts to the federal workforce — threatens scientific progress that drives our economy and improves the public’s health. Slashing federal funding and staff will hobble the very agencies that fuel medical discoveries and approve new treatments. In addition, the...